Overview

The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The study is to evaluate safety, efficacy and pharmacokinetics of intravenously administered fosphenytoin in patients with neurosurgery, head trauma, epilepsy or status epilepticus who are requiring a loading dose of phenytoin.
Phase:
Phase 3
Details
Lead Sponsor:
Nobelpharma
Treatments:
Fosphenytoin
Phenytoin